Senseonics Investor Relations Material
Latest events
Q1 2025
Senseonics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Senseonics Holdings Inc
Access all reports
Senseonics Holdings Inc. is a medical technology company specializing in continuous glucose monitoring (CGM) systems for people with diabetes. The company’s flagship product, the Eversense CGM System, includes a long-term implantable sensor, a wearable transmitter, and a mobile app, providing real-time glucose readings and trend data. Eversense is designed to reduce the frequency of sensor replacements compared to traditional CGM systems. The company is headquartered in Germantown, Maryland, and its shares are listed on the NYSE.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
SENS
Country
🇺🇸 United States